Media Coverage header image

Media Coverage

Advanced Search
  • 04232019
    Chronicle Pharmabiz Online

    Quest Diagnostics, the world's leading provider of diagnostic information services, launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States. The new STD test packages are the first to be offered directly by Quest Diagnostics or any other major national laboratory to allow individuals to purchase tests at their discretion. These new packages have been designed to meet the needs of individuals who want accurate basic or comprehensive STD testing.[CR-LF][CR-LF]The new services are designed to empower individuals to access STD screening when they are reluctant to engage their healthcare provider directly. Research by Quest Diagnostics shows that patients and healthcare providers often fail to discuss sexual behavior and STD risk. According to a survey commissioned by Quest, 51 percent of females age 18-24 years say they don't want to bring up for discussion the topics of sex or STDs with their clinicians and 49 percent claim their clinician has never asked if they want STD testing.

  • 04232019
    Street, The

    Shares of Quest Diagnostics (DGX - Get Report) climbed 7.4% to $91.50 Tuesday after the diagnostic testing company reported better-than-expected first-quarter earnings.[CR-LF][CR-LF]The Secaucus, N.J.-based company reported net income of $164 million, or $1.20 a share, down from $177 million, or $1.52 a share, a year ago. Adjusted earnings came to $1.40 a share, surpassing analyst's forecasts of $1.36.[CR-LF][CR-LF]Revenue totaled $1.89 billion, up 0.4% from a year ago, and beat Wall Street's expectation of $1.87 billion. Cash provided by operations was $275 million, up 53.4% from 2018.

  • 04232019
    Seeking Alpha

    Quest Diagnostics (DGX) Q1 results: Revenues: $1,891M (+0.4%).[CR-LF][CR-LF]Net Income: $164M (-7.3%); Non-GAAP Net Income: $190M (-10.0%); EPS: $1.20 (-5.5%); Non-GAAP EPS: $1.40 (-7.9%); CF Ops: $275M (+52.8%).[CR-LF][CR-LF]2019 Guidance: Revenues: $7.6B - $7.75B (unch); EPS: >$5.16 (unch); Non-GAAP EPS: >$6.40 (unch); CF Ops: ~$1.3B (unch).[CR-LF][CR-LF]The consensus Revenue and GAAP EPS estimate was $1.87B and $1.38, respectively.

  • 04232019
    Seeking Alpha

    Quest Diagnostics (NYSE:DGX): Q1 Non-GAAP EPS of $1.40 beats by $0.02; GAAP EPS of $1.20. Revenue of $1.89B (+0.5% Y/Y) beats by $20M.

  • 04232019
    MedTech Dive

    Tuesday morning's results are the first Quest has shared since getting back into the UnitedHealth network at the start of the year. The agreement with UnitedHealth has given Quest access to more patient lives than at any time in the past decade. Accordingly, organic requisition volume growth was up 2.4%, compared to 1.1% in the fourth quarter of 2018, and would have been around 3% if headwinds including a slightly shorter quarter were excluded.

  • 04232019
    NATAP: National AIDS Treatment Advocacy Project

    Accurate estimates of non-alcoholic steatohepatitis (NASH) prevalence are lacking, particularly the subset of patients with advanced fibrosis. We aim to evaluate prevalence and predictors of advanced fibrosis among patients with probable NASH using national clinical laboratory data. Clinical laboratory data from October 1, 2017-September 30, 2018 were collected using Quest Diagnostics database, which tests ∼30% of U.S. adults annually. Adults with negative hepatitis B surface antigen, negative hepatitis C antibody, and elevated alanine aminotransferase (ALT) (>25 U/L women, >35 U/L men) were evaluated for prevalence of ≥F 3 fibrosis using fibrosis-4 score (FIB-4)>2.67.

  • 04232019
    CNET

    Women's healthcare is historically no fun. I mean, the process of a pap smear speaks for itself. Thankfully, it seems many women feel this way, and some particularly driven women decided to do something about it.[CR-LF][CR-LF]A handful of companies took the most inconvenient and awkward aspects of women's health — like a trip to the gynecologist just for a prescription refill, or checking out at CVS with condoms — and made them much easier.[CR-LF][CR-LF]Modern Fertility emphasizes the convenience and price tag of its products -- no commute or clinic visit, and no sticker shock. You can take your test at home, or opt to take it at a Quest Diagnostics lab if there's one near you.

  • 04232019
    American Journal Managed Care

    In the United States, more than 178 million Americans receive insurance coverage through an employer; of these, approximately 60% have insurance from a self-insured employer. Healthcare costs, both medical and pharmacy, for employers and employees continue to increase at a 6% predicted rate in 2019, on top of the 5 to 6 percent annual increases observed since 2014. The increase in healthcare spending has been directly attributed to increased prices for healthcare services, while utilization has remained somewhat consistent. Today we’re speaking with Dr Steven Goldberg, the vice president of medical affairs, population health, and chief health officer at Quest Diagnostics. He is also a co-author of a recent peer-reviewed case study that analyzed a benefits and wellness program designed by a self-insured employer.

  • 04222019
    UnitedHealthcare

    More affordable procedure costs, shorter wait times, higher quality – everyone wants these things from their health care experience. UnitedHealthcare’s Triple Aim focus – improving health care affordability, outcomes and the patient experience – is now adding more value for lab services. Launching on July 1, 2019, UnitedHealthcare has selected the following labs to participate in its PLN: AmeriPath/DermPath, BioReference, GeneDx, Invitae, LabCorp, Mayo Clinic Laboratories and Quest Diagnostics. These labs were selected based on a rigorous quality review process.

  • 04222019
    Markets Insider

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Quest Diagnostics Incorporated

  • 04222019
    FierceHealthcare

    In 2015, Quest Diagnostics—which has a self-insured employee benefits team—set out on a new path to try to control healthcare costs while maintaining program quality and promoting population health for its employees.[CR-LF][CR-LF]After almost four years, the results of Quest’s group health insurance program were reported in Population Health Management, outlining the collaboration with a health plan and pharmacy benefits manager to practice the “triple aim” of improving the patient healthcare experience, boosting population health and reducing per capita healthcare spending.[CR-LF][CR-LF]The program had a big impact, even in year one. Through proactive changes, physician executive leadership, health plan collaboration, disease-specific population health initiatives and plan design, Quest’s annual healthcare costs steadily improved.

  • 04222019
    PR Newswire - Online

    Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers of 2019. [CR-LF][CR-LF]Quest was among one of only fifteen companies in the Health Care Equipment and Services category to attain the designation.[CR-LF][CR-LF]"Our vision of empowering better health with diagnostic insights is built on the diverse talents of our 46,000 employees, said Steve Rusckowski, Chairman, President and CEO. "It's nice to see that for the third straight year the steps we are taking to create an inspiring workplace are being noticed. Led by our people, the Quest brand is inspiring better health outcomes."

  • 04222019
    Medical Health News

    As Massachusetts health care becomes increasingly dominated by large health systems, more than a dozen community hospitals are banding together in a new partnership. Under the arrangement, called the Massachusetts Value Alliance, hospitals are working together to slash costs by buying some supplies and services together. By teaming up, they have greater leverage in negotiating prices with vendors that sell equipment, software, and other things hospitals need. Several of the hospitals have signed a contract with Quest Diagnostics, a company that processes blood tests. The arrangement allowed the hospitals to lower their costs by contracting together — South Shore said it is saving more than $100,000 a year — while Quest gained a larger customer with more tests to process. Previously, the hospitals each had separate contracts for lab work.

  • 04192019
    FierceBiotech

    Quest Diagnostics has launched three new test kits for sexually transmitted diseases that consumers can order and purchase online directly, within the privacy of their own home. Research has shown that many people and some providers are reluctant to discuss STD screening and disease risks. Quest aims to circumvent this through its QuestDirect program, with its first at-home tests covering the most prevalent STDs in the U.S.—including HIV, hepatitis B and C, syphilis, gonorrhea, chlamydia and trichomonas—and starting at $49 for an individual test. Completing the tests, however, still requires walking in to one of Quest’s patient service centers, including some in grocery stores and retail locations. The kits are now available in the continental U.S., with results available online typically within one week, the company said.

  • 04192019
    Business Insider

    Office happy hours are getting a twist in states where recreational weed is legal, with employees celebrating the end of the workweek by lighting up or snacking on edibles. Most of these companies are in the cannabis business and have offices in pot-friendly states such as Colorado, California, and Oregon (recreational marijuana is legal in 10 states and Washington, DC).According to a recent survey by Drugabuse.com, one in five respondents said they've used marijuana recreationally in their place of work during work hours. A recent report by the clinical laboratory Quest Diagnostics found the number of US workers and job applicants testing positive for drugs has hit a 14-year high, with marijuana-positive tests leading the way.

  • 04182019
    Workboat Online

    The Coast Guard has a message for mariners about to smoke a joint or use CBD (cannabidiol) oil: Don’t risk your job over it — no matter where you live. The growing number of states where some form of marijuana is legal prompted the agency to issue a bulletin this week reminding everyone that marijuana is still illegal under federal law. Ten states and the District of Columbia have approved recreational marijuana for adults, and more than half of all states have OK’d medical marijuana. Marijuana topped the list of most commonly detected illicit substances among U.S. workers, a recent analysis by Quest Diagnostics shows.

  • 04182019
    Business Insider

    With the increased legalization of marijuana, many businesses and politicians are reconsidering workplace drug testing. Though drug testing likely won't disappear forever, experts predict the scope of testing will decrease — and they say the type of testing should change. Earlier this month, a report by clinical laboratory Quest Diagnostics found the number of US workers and job applicants testing positive for drugs hit a 14-year high, with marijuana positivity leading the way.

  • 04172019
    WorkersCompensation.com

    The rate of positive drug tests for illicit substances among U.S. workers in 2018 reached a 14-year peak, with marijuana playing a significant role, according to the annual Drug Testing Index from lab services provider Quest Diagnostics. Researchers analyzed the results of more than 9 million drug tests. They found that 4.4% of the combined U.S. workforce (both the general workforce and employees who undergo federally mandated drug testing) tested positive – up from 4.2% in 2017 and 2016 and the highest since 2004, when the rate was 4.5%.

  • 04172019
    Safety+Health Online

    The rate of positive drug tests for illicit substances among U.S. workers in 2018 reached a 14-year peak, with marijuana playing a significant role, according to the annual Drug Testing Index from lab services provider Quest Diagnostics. Researchers analyzed the results of more than 9 million drug tests. They found that 4.4% of the combined U.S. workforce (both the general workforce and employees who undergo federally mandated drug testing) tested positive – up from 4.2% in 2017 and 2016 and the highest since 2004, when the rate was 4.5%.

  • 04172019
    Antlers American Online

    In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Quest Diagnostics, Inc..

  • 04162019
    Cision PR Web

    The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2019. An extensive process was run to evaluate the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. We gathered data on each nominee’s professional background and assessed them across several key areas including breadth of leadership experience in the healthcare technology industry, level of expertise and domain knowledge in their particular field, depth of their executive team’s experience, and consistency of organizational performance. Steve Rusckowski is Chairman, President and CEO of Quest Diagnostics. He joined the Company as President and CEO in 2012. Under his leadership, Quest has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. Previously, Stephen was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies.

  • 04162019
    Tech Times

    Despite what crime shows depict, New York is less addicted to illegal substances than the other states except for one -- heroin. This is according to the latest data from the Drug Testing Index of Quest Diagnostics. The laboratory obtained the information from analyzing thousands of drug test results of the U.S. workforce from 2007 to 2018.

  • 04162019
    420 Intel

    Workers tested positive for drugs in the workplace at the highest rate in 14 years in 2018, with marijuana use on the rise and opiate use declining, a new study found. An analysis by Quest Diagnostics found drug positivity rates increased nearly five percent in urine drug tests in 2018 and are now more than 25 percent higher than the 30-year low of 3.5 percent recorded between 2010 and 2012.

  • 04162019
    PR Newswire - Online

    One of the arguments for legalization of marijuana is that it would help to ease the opiate epidemic, as marijuana could possibly alleviate opiate withdrawal symptoms and mitigate pain. Some states have approved medical marijuana to treat opiate addiction. The study also found that marijuana use did not help to further alleviate pain. Another important data point comes from Quest Diagnostics, which provides testing services. Workplace testing results showed a 5% increase (2018/2012) in marijuana use in safety-sensitive workers and a related rise in the use of opiate painkillers, while the rate of positive opiate results for the broader workforce fell.

  • 04152019
    WTVD-TV Online

    The Southern Women's Show has drawn crowds to Raleigh for 34 years, and Sunday's edition continued that tradition. The organization says the free screenings they offer are brief, but can reveal important information. The organization's tests include screenings for five risk factors associated with heart disease. "We get it done in about 15 minutes and we can tell them 'Ok, your blood pressure is this and your cholesterol is this, and we suggest that you go to the doctor,'" said Rosie Barretta of Quest Diagnostics.

Show 5102550100 per page